Atherogenic Dyslipidemia Patterns And Hypertension Severity In Type 2 Diabetes Mellitus: A Systematic Review And Meta-Analysis
Article Sidebar
Main Article Content
Abstract
Atherogenic dyslipidemia and hypertension frequently co-occur in Type 2 Diabetes Mellitus (T2DM), yet the precise impact of composite lipid patterns on blood pressure severity requires comprehensive evaluation. This study conducted a systematic review of six observational studies encompassing over 7.6 million individuals to quantify this relationship. The quantitative synthesis demonstrated a highly significant positive association, revealing that patients with elevated atherogenic indices such as the Atherogenic Index of Plasma (AIP) or Lipoprotein Combined Index (LCI) that exhibited a 35% greater likelihood of experiencing severe, poorly controlled hypertension compared to those with normative profiles. Ultimately, atherogenic dyslipidemia acts as a significant, independent driver of hypertension severity. To optimize cardiovascular risk reduction, clinical management protocols for diabetic hypertension must evolve beyond isolated LDL-C targets to systematically address comprehensive atherogenic lipid profiles.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Amadi, C. E., Mbakwem, A. C., Duro, D. C., Udenze, I. C., Akinsola, C. M., Ajuluchukwu, J. N., & Oke, D. A. W. (2022). Prevalence, patterns and predictors of metabolic abnormalities in Nigerian hypertensives with hypertriglyceridemic waist phenotype: A cross sectional study. PLOS Global Public Health, 2(12), Article e0001203. https://doi.org/10.1371/journal.pgph.0001203
Dalal, J., Chandra, P., Chawla, R., Kumar, V., Abdullakutty, J., Natarajan, V., Naqvi, S. M. H., Gaurav, K., Rathod, R., Dhanaki, G., Kotak, B., & Shah, S. (2024). Clinical and demographic characteristics of patients with coexistent hypertension, type 2 diabetes mellitus, and dyslipidemia: A retrospective study from India. Drugs - Real World Outcomes, 11, 167–176. https://doi.org/10.1007/s40801-023-00400-3
Goyal, R., Singhal, M., & Jialal, I. (2023). Type 2 diabetes. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513253/
Hong, S. P., Kim, C. Y., & Jung, H. W. (2023). The comparison of the associations of lipoprotein(a) and the atherogenic index of plasma with coronary artery calcification in patients without high LDL-C: A comparative analysis. Journal of Lipid and Atherosclerosis, 12(2), 152–163. https://doi.org/10.12997/jla.2023.12.2.152
International Diabetes Federation. (2025). IDF Diabetes Atlas (11th ed.). International Diabetes Federation. https://diabetesatlas.org
Kim, S. H., Cho, Y. K., Kim, Y. J., Jung, C. H., Lee, W. J., Park, J. Y., Huh, J. H., Kang, J. G., Lee, S. J., & Ihm, S. H. (2022). Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: A nationwide population-based cohort study. Cardiovascular Diabetology, 21, Article 81. https://doi.org/10.1186/s12933-022-01522-8
Lumu, W., Bahendeka, S., Wesonga, R., Kibirige, D., Kasoma, R. M., & Ssendikwanawa, E. (2023). Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda. African Health Sciences, 23(1), 515–527. https://doi.org/10.4314/ahs.v23i1.54
Vybhavi, V. S. J., Bhavsar, M., Gusani, J., Gohil, Y., Paul, N. K., Garlapati, H. R., & Shrivastava, K. (2025). New insights into the pathophysiology of type 2 diabetes: A review article. Journal of Pharmacy and Bioallied Sciences, 17(Suppl 2), S1070–S1072. https://doi.org/10.4103/jpbs.jpbs_1759_24
Zhao, K., & Ling, S. (2025). Gender-specific association between a novel atherogenic index of plasma, metabolic parameters and inflammation among obese adults. BMC Endocrine Disorders, 25, Article 38. https://doi.org/10.1186/s12902-024-01813-z